Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FREQ

Frequency Therapeutics (FREQ) Stock Price, News & Analysis

Frequency Therapeutics logo

About Frequency Therapeutics Stock (NASDAQ:FREQ)

Advanced Chart

Key Stats

Today's Range
$0.28
$0.32
50-Day Range
$0.22
$14.98
52-Week Range
$0.18
$16.00
Volume
309,164 shs
Average Volume
822,537 shs
Market Capitalization
$10.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Stock News Headlines

Transform with 528Hz Frequency 🔊
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
Trevi Therapeutics RIVER trial meets primary endpoint
Trevi Therapeutics RIVER trial meets primary endpoint
Silence Therapeutics Advances Promising siRNA Therapy for PV
See More Headlines

FREQ Stock Analysis - Frequently Asked Questions

Frequency Therapeutics, Inc. (NASDAQ:FREQ) released its quarterly earnings data on Monday, November, 15th. The company reported ($0.73) EPS for the quarter, missing the consensus estimate of ($0.57) by $0.16.

Frequency Therapeutics (FREQ) raised $102 million in an initial public offering (IPO) on Thursday, October 3rd 2019. The company issued 6,700,000 shares at $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Mizuho Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Frequency Therapeutics investors own include Tesla (TSLA), ImmunoGen (IMGN), Advanced Micro Devices (AMD), AMC Entertainment (AMC), Ovintiv (OVV), Plug Power (PLUG) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/15/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FREQ
CIK
1703647
Fax
N/A
Employees
46
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.58 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.07 million
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
0.15

Miscellaneous

Free Float
30,385,000
Market Cap
$10.94 million
Optionable
Not Optionable
Beta
0.84
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:FREQ) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners